[HTML][HTML] Diagnosis of severe respiratory infections in immunocompromised patients

E Azoulay, L Russell, A Van de Louw, V Metaxa… - Intensive care …, 2020 - Springer
An increasing number of critically ill patients are immunocompromised. Acute hypoxemic
respiratory failure (ARF), chiefly due to pulmonary infection, is the leading reason for ICU …

Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review

G El Helou, RR Razonable - Infection and drug resistance, 2019 - Taylor & Francis
Cytomegalovirus (CMV) is a leading opportunistic infection in immune compromised
patients, including allogeneic hematopoietic stem cell (HSCT) or solid organ transplant …

Uterine transplantation: review of livebirths and reproductive implications

BP Jones, L Kasaven, S Vali, S Saso… - …, 2021 - journals.lww.com
Uterine transplantation (UTx) is a fertility restoring treatment for women with absolute uterine
factor infertility. At a time when there is no question of the procedure's feasibility, and as the …

Living donor uterus transplant in the UK: A case report

BP Jones, S Vali, S Saso, A Devaney… - … of obstetrics and …, 2024 - pubmed.ncbi.nlm.nih.gov
Living donor uterus transplant in the UK: A case report Living donor uterus transplant in the UK:
A case report BJOG. 2024 Feb;131(3):372-377. doi: 10.1111/1471-0528.17639. Epub 2023 …

Human cytomegalovirus infection in women with preexisting immunity: sources of infection and mechanisms of infection in the presence of antiviral immunity

WJ Britt - The Journal of Infectious Diseases, 2020 - academic.oup.com
Human cytomegalovirus (HCMV) infection remains an important cause of
neurodevelopmental sequelae in infants infected in utero. Unique to the natural history of …

Drug-resistant cytomegalovirus infection after lung transplantation: Incidence, characteristics, and clinical outcomes

E Heliövaara, S Husain, T Martinu, LG Singer… - The Journal of Heart and …, 2019 - Elsevier
Background Cytomegalovirus (CMV) infection and development of CMV drug resistance can
cause significant morbidity and mortality in patients with lung transplantation (LTX). We …

[HTML][HTML] Cytomegalovirus in renal transplant recipients from living donors with and without valganciclovir prophylaxis and with immunosuppression based on anti …

J Andrade-Sierra, A Heredia-Pimentel… - International Journal of …, 2021 - Elsevier
Background In our population, anti-thymocyte globulin (ATG) of 1 mg/Kg/day for 4 days is
used; which permits not using valgancyclovir (VGC) prophylaxis in some renal transplant …

Association of CMV‐specific T‐cell immunity and risk of CMV infection in lung transplant recipients

T Veit, M Pan, D Munker, P Arnold, A Dick… - Clinical …, 2021 - Wiley Online Library
Background Protecting against CMV infection and maintaining CMV in latent state are
largely provided by CMV‐specific T‐cells in lung transplant recipients. The aim of the study …

[HTML][HTML] Early immune surveillance to predict cytomegalovirus outcomes after allogeneic hematopoietic stem cell transplantation

J Xia, X Li, G Gui, J Wu, S Gong, Y Shang… - Frontiers in Cellular and …, 2022 - frontiersin.org
Background There is no method of predicting human cytomegalovirus (HCMV) outcomes in
allogeneic hematopoietic stem cell transplant recipients clinically, leading in some cases to …

Prevention and therapy of viral infections in patients with solid organ transplantation

JT Silva, M Fernández-Ruiz, JM Aguado - Enfermedades Infecciosas y …, 2021 - Elsevier
Solid organ transplantation (SOT) is the best treatment option for end-stage organ disease.
The number of SOT procedures has been steadily increasing worldwide during the past …